Please check your internet connection and try again.
## Ecospirin (Aspirin Enteric-Coated)
**Overview:**
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) belonging to the salicylate class. The enteric coating is designed to delay the dissolution of the tablet until it reaches the more alkaline environment of the small intestine, which may reduce gastric irritation.
**Primary Indications:**
* Pain relief (mild to moderate)
* Fever reduction
* Inflammation reduction
* Antiplatelet therapy (e.g., prevention of cardiovascular events)
**Adult Dosing:**
Dosing varies significantly based on indication:
* **Analgesic/Antipyretic/Anti-inflammatory:** Typically 325 mg to 650 mg every 4 to 6 hours as needed. Maximum daily dose generally not to exceed 4 grams.
* **Antiplatelet (Primary/Secondary Cardiovascular Prevention):** Typically 75 mg to 100 mg once daily. Higher doses (e.g., 325 mg daily) may be used in specific acute settings. Consult local guidelines or specialist recommendations.
**Pediatric Dosing:**
Aspirin is generally **not recommended** for children and teenagers due to the risk of Reye's syndrome, a rare but serious condition associated with viral infections (e.g., influenza, chickenpox). Specific indications and dosing for pediatric use, if any, should only be determined by a specialist and with extreme caution, typically in very specific circumstances like Kawasaki disease.
**Dose Adjustments:**
* **Renal Impairment:** Use with caution. Severe renal impairment may require dose reduction or avoidance.
* **Hepatic Impairment:** Use with caution. May exacerbate liver disease.
**Contraindications:**
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* History of bronchospasm, urticaria, or allergic-type reactions after taking aspirin or NSAIDs.
* Active peptic ulcer disease or gastrointestinal bleeding.
* Children and teenagers with viral infections (risk of Reye's syndrome).
* Third trimester of pregnancy.
* Severe hepatic or renal impairment.
* Certain bleeding disorders.
**Adverse Effects:**
* **Common:** Dyspepsia, heartburn, nausea, abdominal pain, rash.
* **Serious:** Gastrointestinal bleeding/perforation, tinnitus, hearing loss, bronchospasm, allergic reactions, Reye's syndrome (in children/teenagers), nephrotoxicity, hepatotoxicity.
**Key Drug Interactions:**
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of gastrointestinal toxicity and bleeding.
* **Corticosteroids:** Increased risk of gastrointestinal bleeding.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Alcohol:** Increased risk of gastrointestinal irritation and bleeding.
* **Methotrexate:** Aspirin can increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin can reduce the effectiveness of these agents.
**Monitoring:**
* Signs and symptoms of gastrointestinal bleeding (e.g., melena, hematemesis, abdominal pain).
* Tinnitus or hearing changes.
* Renal and hepatic function, especially with long-term use or in patients with risk factors.
* Platelet function if antiplatelet effects are critical.
**Clinical Pearls:**
* The enteric coating helps reduce direct gastric irritation but does not eliminate the systemic risk of gastrointestinal bleeding. Take with food or milk if gastric upset occurs despite coating.
* Avoid concomitant use with other NSAIDs unless specifically indicated and managed.
* For antiplatelet therapy, consistent daily dosing is crucial.
* Tinnitus is an early sign of salicylate toxicity.
***
*This information is intended for clinical use and does not substitute for professional medical advice. Always verify current prescribing information and consult relevant guidelines before making any treatment decisions.*
